Genprex Inc (GNPX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.71M
Last updated: Nov 17, 2026 at 11:04 AM ET
Genprex Inc (GNPX) Competitors
The companies most similar to Genprex are XORTX Therapeutics (XRTX), Enlivex Therapeutics (ENLV) and Kairos Pharma (KAPA). By market cap, Genprex ranks 12th of the 13 companies on this page; Traws Pharma (TRAW) is the largest at $3.86M.
Peer Comparison
GNPX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Genprex (GNPX) | $1.71M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| XORTX Therapeutics Inc (XRTX) | $2.00M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Enlivex Therapeutics Ltd (ENLV) | $1.82M | N/A | N/A | 0.0% | -0.3% | 0.0% | 0.00% |
| Kairos Pharma, Ltd. (KAPA) | $1.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Jupiter Neurosciences, Inc. Common Stock (JUNS) | $2.32M | N/A | 21.0x | 0.0% | 1154.5% | 0.0% | 0.00% |
| Onconetix Inc (ONCO) | $2.15M | N/A | 1.0x | 0.0% | N/A | -83.9% | 0.00% |
| Purple Biotech (PPBT) | $2.65M | N/A | N/A | 0.0% | -156.2% | 0.0% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) | $1.82M | N/A | 1.7x | 0.0% | N/A | -32.5% | 0.00% |
| Traws Pharma Inc (TRAW) | $3.86M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| BioRestorative Therapies Inc (BRTX) | $2.06M | N/A | 70.3x | 0.0% | -289.9% | -7.3% | 0.00% |
| Mustang Bio Inc (MBIO) | $3.20M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $2.24M | N/A | 1.7x | 0.0% | -78.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Genprex, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| XORTX Therapeutics Inc (XRTX) | XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease... | XRTX competitors |
| Enlivex Therapeutics Ltd (ENLV) | Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel. | ENLV competitors |
| Kairos Pharma, Ltd. (KAPA) | Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. | KAPA competitors |
| Jupiter Neurosciences, Inc. Common Stock (JUNS) | Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company... | JUNS competitors |
| Onconetix Inc (ONCO) | Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions. | ONCO competitors |
| Purple Biotech (PPBT) | Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United... | PPBT competitors |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) | 60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention... | SXTP competitors |
| Traws Pharma Inc (TRAW) | Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. | TRAW competitors |
| BioRestorative Therapies Inc (BRTX) | BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue... | BRTX competitors |
| Mustang Bio Inc (MBIO) | Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures... | MBIO competitors |
Frequently Asked Questions About GNPX
Who are Genprex's main competitors?
The companies most similar to Genprex include XORTX Therapeutics (XRTX), Enlivex Therapeutics (ENLV), Kairos Pharma (KAPA), Jupiter Neurosciences, Inc. Common Stock (JUNS) and Onconetix (ONCO), listed from the closest match.
Who is Genprex's biggest competitor?
Traws Pharma (TRAW) is the largest of the similar companies at $3.86M; XORTX Therapeutics (XRTX) is the closest match by business profile, size, sector and industry.
How does GNPX stock compare with its competitors?
GNPX's net margin is 0.0% against a peer median of 0.0%.
Which of Genprex's competitors pays a higher dividend?
Genprex pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Genprex bigger than its competitors?
No. Genprex is 12th by market cap among the 13 companies on this page; the largest is Traws Pharma (TRAW) at $3.86M.
GNPX pages: Overview, Earnings, Financials, Competitors